MENU
GERN
AS OF
Nov 13, 04:59 PM (EDT)
Price
$1.16
Change
-$0.09 (-7.26%)
Capitalization
797.94M
119 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
GERN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Geron (GERN) Earnings Date & Reports

Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

GERN is expected to report earnings to rise 16.33% to -3 cents per share on March 12

Geron GERN Stock Earnings Reports
Q4'25
Est.
$-0.03
Q3'25
Est.
$-0.03
Q2'25
Beat
by $0.01
Q1'25
Est.
$-0.03
Q4'24
Missed
by $0.01
The last earnings report on November 05 showed earnings per share of -2 cents, meeting the estimate of -2 cents. With 4.14M shares outstanding, the current market capitalization sits at 797.94M.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
GERN
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. GERN showed earnings on November 05, 2025. You can read more about the earnings report here.
View AI-Driven Trading for GERN
A.I. Advisor
published General Information

General Information

a developer of therapeutic products for cancer

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
919 East Hillsdale Boulevard
Phone
+1 650 473-7700
Employees
141
Web
https://www.geron.com